Facial Injectables Market likely to surpass USD 37.1 Bn by 2031, expanding at a 12.0% CAGR: TMR Report

The global 𝐟𝐚𝐜𝐢𝐚𝐥 𝐢𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, valued at US$ 13.5 billion in 2022, is poised for substantial growth, projected to advance at a commendable CAGR of 12.0% from 2023 to 2031, reaching US$ 37.1 billion by the end of 2031.

This surge is attributed to several factors including the increasing popularity of non-invasive cosmetic procedures, coupled with a rise in disposable income and evolving consumer preferences worldwide. With a growing number of individuals opting for facial injectables to address aesthetic concerns, the demand for dermal fillers and botulinum toxin treatments is witnessing a significant uptick as people seek to enhance their appearance and combat signs of aging. Moreover, the aging population's desire to maintain a youthful look is anticipated to further bolster market expansion. Accessibility and affordability of these treatments, particularly in emerging economies, are also contributing factors expected to propel the global facial injectables market size.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1779&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

Facial injectables encompass dermal fillers and botulinum toxin, which are used to enhance appearance and address aesthetic concerns. Dermal fillers are gel-like substances injected to restore volume, smoothen wrinkles, and improve facial contours.

Facial injectables provide a non-invasive solution for achieving a more youthful and rejuvenated look. Dermal fillers typically contain hyaluronic acid, calcium hydroxylapatite, or poly-L-lactic acid, while Botox is a neurotoxic protein. These treatments are performed by qualified professionals and offer temporary results, usually lasting several months to a year.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Allergan, Inc., Ipsen (Mayroy SA), Merz Pharma, Suneva Medical, Inc., Medytox, Inc., Sinclair Pharma, Bloomage BioTechnology, Anika Therapeutics, Inc., Prollenium Medical Technologies, and Galderma

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞

Collagen
Hyaluronic Acid (HA)
Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Polymethylmethacrylate Beads (PMMA Microspheres)
Poly-L-Lactic Acid (PLLA)
Others (Polyalkylimide)

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Facial Line Correction
Lip Augmentation
Acne Scar Treatment
Face Lift
Lipoatrophy Treatment
Others (earlobe rejuvenation)

𝐄𝐧𝐝-𝐮𝐬𝐞𝐫

Hospitals
Dermatology Clinics
Others (beauty clinics)

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In May 2023, Evolus, a leading company, announced entry into the U.S. dermal filler market with the introduction of Evolysse. This first-generation cold technology hyaluronic acid (HA) product, developed by Symatese, marks a significant expansion for Evolus. Additionally, Evolus has a portfolio of five fillers currently in late-stage development, with the anticipation of the first approval in the first half of 2025.

In January 2023, Galderma unveiled a revolutionary solution called FACE by Galderma, aimed at assisting healthcare professionals in expanding their practice and enhancing patient satisfaction. This cutting-edge augmented reality application employs digital facial assessment to simulate the outcomes of injectable treatments in real time. With advanced wrinkle detection and dynamic "before and after" images showcasing 19 different injectable treatments, the application offers a comprehensive approach to personalized care.

In May 2021, AbbVie's subsidiary, Allergan Aesthetics, received FDA approval for SKINVIVE by JUVÉDERM. This groundbreaking product is designed to enhance cheek smoothness in adults aged 21 and above. It is the sole hyaluronic acid (HA) intradermal microdroplet injection available in the U.S., offering long-lasting results for up to six months when used optimally. This development marks a significant advancement in aesthetic treatments, providing individuals with an effective solution for improving the texture of their skin.

𝐏𝐥𝐚𝐜𝐞 𝐚𝐧 𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=1779<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

As per facial injectables market trends, North America accounted for leading market share in 2022. This is ascribed to large population seeking aesthetic enhancements, strong emphasis on youthful appearances, and high disposable income among consumers.

The market in Asia Pacific is experiencing rapid growth driven by factors such as large population, increase in disposable income, growing beauty consciousness, and rise in demand for non-surgical cosmetic procedures. The market in the region is characterized by expanding aesthetic clinics, advancements in technology, and strong presence of key market players.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

One notable trend in the facial injectables market is the shift towards natural and biocompatible injectable materials, driven by concerns over synthetic fillers' longevity and safety. Additionally, the rise of combination therapies, such as combining botulinum toxin with dermal fillers for comprehensive facial rejuvenation, is gaining traction among consumers.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future of the facial injectables market looks promising, with continued innovations in product formulations and techniques. Advancements in stem cell-based therapies and personalized treatments are anticipated to shape the market landscape further, catering to individual aesthetic preferences and patient needs.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Key areas of focus for market research include consumer preferences, market dynamics, regulatory landscape, technological advancements, competitive analysis, and emerging market trends.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐄𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/10/2665345/0/en/Patient-Engagement-Solutions-Market-to-Reach-USD-56-33-Bn-by-2028-growing-at-a-CAGR-of-15-7-Global-Analysis-by-TMR.html

𝐈𝐧𝐟𝐫𝐚𝐫𝐞𝐝 𝐒𝐞𝐧𝐬𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/11/2667369/0/en/Infrared-Sensors-Market-is-Expected-to-Accelerate-at-a-Whopping-5-4-CAGR-Reaching-US-1-1-Billion-by-2031-Transparency-Market-Research.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com        
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.